Alex Preston

936 total citations
7 papers, 73 citations indexed

About

Alex Preston is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Alex Preston has authored 7 papers receiving a total of 73 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Hematology and 2 papers in Organic Chemistry. Recurrent topics in Alex Preston's work include Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Click Chemistry and Applications (2 papers). Alex Preston is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Multiple Myeloma Research and Treatments (3 papers) and Click Chemistry and Applications (2 papers). Alex Preston collaborates with scholars based in United Kingdom, United States and Germany. Alex Preston's co-authors include Robert J. Watson, Ian D. Wall, Stephen J. Atkinson, Rab K. Prinjha, Emmanuel H. Demont, S. Taylor, Chun‐wa Chung, Paola Grandi, Inmaculada Rioja and Gang Yao and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry and Chemical Physics Letters.

In The Last Decade

Alex Preston

7 papers receiving 71 citations

Peers

Countries citing papers authored by Alex Preston

Since Specialization

Citations

This map shows the geographic impact of Alex Preston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Preston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Preston more than expected).

Fields of papers citing papers by Alex Preston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Preston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Preston. The network helps show where Alex Preston may publish in the future.

Co-authorship network of co-authors of Alex Preston

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Preston. A scholar is included among the top collaborators of Alex Preston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Preston. Alex Preston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Design and Characterization of 1,3-Dihydro-2H-benzo[d]azepin-2-ones as Rule-of-5 Compliant Bivalent BET Inhibitors 2023 ·ACS Medicinal Chemistry Letters ·Paul Bamborough, Chun‐wa Chung, Nicole C. Goodwin, Darren J. Mitchell, (unknown), (unknown), Alex Preston, Rab K. Prinjha, Peter E. Soden, Robert J. Watson, Emmanuel H. Demont	1
2	Multigram Synthesis of Tetrasubstituted Dihydrobenzofuran GSK973 Enabled by High-Throughput Experimentation and a Claisen Rearrangement in Flow 2022 ·Organic Process Research & Development ·Catherine M. Alder, Matthew Gray, Chelsea A. Huff, (unknown), Alex Preston, (unknown), Leanna E. Shuster, Robert J. Watson, Katherine M. P. Wheelhouse, Glynn D. Williams, Emmanuel H. Demont	3
3	Global rovibrational fits for AlCl, BiCl, and BiF: Benchmarks for novel physics 2022 ·Chemical Physics Letters ·Alex Preston, (unknown), Richard Mawhorter	5
4	Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening Hit 2021 ·Journal of Medicinal Chemistry ·(unknown), Stephen J. Atkinson, Chun‐wa Chung, Paola Grandi, James R. Gray, (unknown), Patrícia Flores de Medeiros, (unknown), (unknown), Alex Preston, Rab K. Prinjha, Inmaculada Rioja, Alexander L. Satz, S. Taylor, Ian D. Wall, Robert J. Watson, Gang Yao, Emmanuel H. Demont	33
5	Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors 2021 ·Journal of Medicinal Chemistry ·Simon C. C. Lucas, Stephen J. Atkinson, Chun‐wa Chung, (unknown), Laurie Gordon, Paola Grandi, (unknown), (unknown), (unknown), Alex Preston, Rab K. Prinjha, Inmaculada Rioja, S. Taylor, Nicholas C. O. Tomkinson, Ian D. Wall, Robert J. Watson, James M. Woolven, Emmanuel H. Demont	20
6	Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Neil Garton, Michael D. Barker, (unknown), (unknown), (unknown), Emma J. Jones, Huw D. Lewis, John Liddle, Dave Lugo, Scott McCleary, Alex Preston, César Ramírez-Molina, Margarete Neu, (unknown), Don O. Somers, Robert J. Watson, David M. Wilson	8
7	Diarrhea events in cancer patients (pts) treated with lapatinib 2007 ·Journal of Clinical Oncology ·María Koehler, Stephen Chan, B. Newstat, Alex Preston, Howard A. Burris	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact